Bowel (colorectal) cancer, Colon cancer, Rectal cancer
Open
Phase 2
This trial is looking to see if having pembrolizumab before surgery improves treatment for bowel cancer that has a high risk of coming back.
It is for people who:
are going to have surgery to remove their cancer and
have certain gene changes () in their cancer cells
Recruitment start: 20 July 2022
Recruitment end: 31 March 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Kai-Keen Shiu
Cancer Research UK & UCL Cancer Trials Centre
Merck, Sharp & Dohme
University College London (UCL)
Last reviewed: 9 July 2025
CRUK internal database number: 18561
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
